blood sampling and/or blood pressure measurement, and inexpensive.
An electrode designed for this purpose was first described by Parker in 19713 and used by Huch in newborns. 4 Modification of this electrode has since been incorporated into untbilical arterial catheters to allow monitoring of oxygen tension in premature infants to prevent hypoxaemia and to minimize the occurrence of retrolental fibroplasia. 5 This electrode has also been mounted on catheter tips for monitoring of PQ in critically ill patients, ~ The early sensors, however, were fraught with problems including wide in vivo drift partly due to fibrin deposition, and partly due to flow dependency. As well, some sensors simply failed to activate. Many of these problems have been overcome with the current generation of sensors. In vivo drift is now Jess than ten per cent in 24 hours, stabilization time is about ten minutes, and 90 per cent response to change in oxygenation is complete within 120 seconds. It is little influenced by change in flow, and change in temperature can be corrected. 7 Good correlations have been demonstrated in critically ill patients and newborn infants. 6's In a comparative study in premature infants, Finer showed that more episodes of hypoxaemla were observed with the continuous PO2 sensor than using the conventional method of intermittent blood gas sampling. 9 Few studies have been conducted during anaesthetic conditions, and our own study indicated that its performance was satisfactory during hypotensive anaesthesia, m Despite these promising reports, this type of monitoring has not gained popularity and there are many reasons. In lerms of anaesthetic applications, it cannot be used during halothane anaesthesia because halothane is also reduced at the cathode and causes a falsely high reading. The technique requires an in situ blood sample calibration, and in order to allow simultaneous recording of arterial blood pressure, at least an 18-gauge catheter must Joe used. Perhaps the most important reasons against its routine use are the invasive nature of the moni|or and the cost entailed. The lack of clear indications foJ" its use also hamper its utilization.
A newer generation of catheter tip-mounted sensors with further improvement over predecessors is now being developed. Heparin-bonded catheters will minimize fibrin deposit and therefore decrease the in vivo drift. The utilization of fiberoptic sensors will allow not only on-line PO2 monitoring, but also PCO2 as well as pH. Although these new sensors have not yet reached the stage of clinical trial and the cost factor remains a prohibitive one, the need for a method of continuously measuring the oxygen tension of blood in vivo exists today as it did ten years ago and though ear or pulse oximetry would satisfy the demand for continuous monitoring of oxygenation in most situations, in seleeted eases where invasive monitoring is indicated and where raidly deteriorating arterial oxygenation can occur, continuous monitoring of PO2 would be highly desirable. 
Mixed venous oxygen saturation
The development of flow-directed balloon-lipped catheters has provided the opportunity to measure pulmonary artery pressures, pulmonary occlusion pressures ("wedge" pressure) and cardiac outputs on a routine basis. Use of these data can be improved by obtaining and interpreting continuous mixed venous oxygen saturations (S~O2) from the pulmonary artery catheter. Only thoroughly mixed blood which flows from capillary beds that extract oxygen v~hile not being contaminated by blood which may have bypassed capillaries due to pro-or post-capillary shunts can be considered true mixed venous blood. Pulmonary arterial blood, with rare exceptions, fulfills these requirements. S~O2 reflects the status of the oxygen supply/transport system. This system consists of oxygen demand and oxygen extraction components. J Oxygen demand is directly related to the metabolic rate which may be attered by anaesthetics, temperature, endocrine function, muscular work and disease states such as sepsis and shock. The oxygen requirements of each organ vary according to the activity of the organ and regional differences commonly occur. Oxygen extraction, or oxygen consamption, is the amount of oxygen actually used by the cells, tissue and organs. Under normal and steady-state conditions, oxygen demand and oxygen extraction are equal. The oxygen transport system may be so compromised in shock that demand exceeds extraction resulting in anaerobic metabolism producing lactic acidosis. Such an event is invariably associated with life-threatening disease and an ominous prognosis.
Oxygen supply/transport to cells and tissues is dependent on cardiac output, haemoglobin concentration and the arterial oxygen saturation. With a cardiac output of 5 L-rain -t, a haemoglobin of 15 g.dL -I, an arterial Oz saturation of 97 per cent and normal oxygen extraction, the S~O2 will approximate 75 per cent. 2 Any disease process which causes anaemia, decreased cardiac output or arterial 02 desaturatinn stimulates compensatory processes to meet the oxygen demand by increasing cardiac output or increasing oxygen extraction. Cardiac output may triple (from 5 to 15L.min -~) while S~O2 may decrease to as little as 31 per cent thus tripling the arterial-venous oxygen saturation difference from a normal of 22 per cent (97 to 75 per cent) to 66 per cent (97 to 31 per cent). A nine-fold protective mechanism is thus possible assuming cardiac performance and tissue extraction are not compromised. 2 Compensatory mechanisms may include changes in viscosity, vasodilation, preload, afterload, sympathetic tone and increased oxygen extraction. The onset of lactic acidosis heralds the inability to meet oxygen consumption requirements. Once this finite level of S~O2 is reached, compensatory mechanisms for matching oxygen demand arid oxygen consumption are exhausted. This key value of S'7'O2 is difficult to estimate because of metabolic and shunt factors -a commonly accepted value is a $902 of less than 40 per cent. As a general rule, a significant decrease in S';'O2 (10-20 per cent) indicates to the clinician that a careful review of the patient is indicated) An absolute value of S';'O2 less than 40 per cent suggests compensatory mechanisms have been exhausted, with lactic acidosis likely to evolve with a corresponding dismal prognosis (Table) .
These conclusions are supported by correlations observed between S'~O2 and the prognosis in respiratory failure, 4 myocardial infarction, s septic shock, 6 cardiac tamponade 3 and tension pneumothorax.7 Reversal of the falling SvO2 or reversal of the trend indicated by continuous monitoring, has resulted in improved management of patients in a postoperative cardiac unit. 3 Seemingly paradoxical increases in S'~O2 may be seen in patients who clinically have compromised tissue oxygenation. This situation occurs in some cases of sepsis where the Sg'O2 exceeds 60 per cent in the presence of lactic acidosis. A failure of oxygen extraction or contamination of mixed venous blood due to peripheral arteriolar shunts, may occur in haemorrhag[c or septic shock. Maldislrlbution of blood flow (shifts from skin, kidney) may result in lactic acidosis in the end organ with cencemttant normal SvO2 values. A normal or high SvO2 in the presence of significant hypotension suggests that an immediate review of the patient is necessary.
This discussion can be summarized by reviewing the 
Monitoring with transcutaneous P02 and pulse oximetry devices
Thus when Sad2 is 100 per cent continuous S'~O2 measurement reflects continuous oxygen extraction. The normal patient with $902 of 75 per cent has an oxygen extraction ratio of 25 per cent based on the assumptions of close to 100 per cent arterial saturation, negligible oxygen in solution, constant haemoglobin and no lactic acidosis.
This expression allows one to continuously track oxygen transport variables as shown in the Table, even  though there may not be a direct correlation with cardiac  Output alenr Continuous Sr,'Oz monitoring may provide early warning of a deleterious event in a patient's recovery process. This useful indicator of eirculatoi3' imbalance may help in the intraoperative management of the difficult patient such as those undergoing cardiac surgery, vascular surgery or those who are haemodynamically unstable or in shock.
In spite of its paramount importance, oxygenation has only been monitored in the past by the absence of the clinical signs of inadequate oxygenation. These signs, which include cyanosis, tachycardia or bradycardia, hypertension or hypotension, hyperventilation or hypoventilation, are subjective, nonspecifie and unreliable. Over the past 20 years technological advances have allowed the development of devices for the objective assessment of oxygenation, first by analysis of blond samples and more recently, by continuous monitoring techniques.
This article will describe "~he experimental and clinical aspects of the two currently available noninvasive oxygen monitoring techniques: transcutaneous PO2 (PtcOz) and pulse oximetry (NSaO2).
Transcutanenus PO2 (Ptr
The transcutaneous oxygen sensor utilizes a polarographic oxygen electrode to measure oxygen that diffuses to the skin surface from the dermal capillary bed beneath it. To obtain a reliable PO2 reading with a fast response time, the skin must be heated to at least 43 ~ C. The heat affects the three basic layers of the skin, which in turn influence the PO2 measured at the surface. The increase in
